Wall Street's major averages plummeted on Friday after Israel and Iran traded missile strikes and stoked concerns of an ...

BioNTech (NASDAQ:BNTX) has agreed to acquire its German rival CureVac (NASDAQ:CVAC) in an all-stock transaction worth nearly ...

The S&P 500 and Nasdaq are heading for weekly wins after inflation data and tech strength boosted confidence, but the Dow is weighed down ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

BioNTech continued to grow its oncology business by agreeing to buy fellow German biotech CureVac for $1.25 billion in a deal that combines two of the world's leaders in mRNA treatments.

Plus: Oracle posts strong quarterly results boosted by the company's artificial-intelligence investments. Biotech company BioNTech acquires CureVac. Adobe raises its full-year outlook after posting ...

Wholesale data showed milder inflationary pressures while Trump renewed his threat to impose "take it or leave it" tariffs on ...

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...

Dow Jones Top Company Headlines at 3 PM ET: Micron Technology to Invest $200 Billion in U.S. Semiconductor Manufacturing | Boeing ... Micron Technology to Invest $200 Billion in U.S. Semiconductor ...